Abstract
A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have